Ibere Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Total operating expenses were $1,004,148.
Profit Margin
| 2021 | 0 | 1.56M |
|---|
IBER Income Statement (2021 – 2021)
| 2021 | |
|---|---|
Revenue | |
Revenue | 0 |
Cost of revenue | 1.00M |
Gross profit | -1.00M |
Operating exp. | |
Research and development | 0 |
Selling and marketing | 0 |
Total operating expenses | 1.00M |
Operating income | -1.00M |
Other income (expenses), net | 2.56M |
Income before tax | 1.56M |
Income tax expense | -17.11K |
Net income | 1.56M |
Earnings per share | |
Basic EPS | 0.34 |
Diluted EPS | 0.34 |
| Data source |